OpGen (OPGN) Short Interest Ratio & Short Volume → Biotech's Best Kept Secret: Potential 46,751% Gain (From Behind the Markets) (Ad) Free OPGN Stock Alerts $3.06 -0.35 (-10.26%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends OpGen Short Interest DataCurrent Short Interest7,800 sharesPrevious Short Interest191,400 sharesChange Vs. Previous Month-95.92%Dollar Volume Sold Short$34,273.20Short Interest Ratio0.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares1,260,000 sharesFloat Size1,220,000 sharesShort Percent of Float0.64%Today's Trading Volume74,086 sharesAverage Trading Volume33,158 sharesToday's Volume Vs. Average223% Short Selling OpGen ? Sign up to receive the latest short interest report for OpGen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOPGN Short Interest Over TimeOPGN Days to Cover Over TimeOPGN Percentage of Float Shorted Over Time Ad Behind the MarketsBiotech's Best Kept Secret: Potential 46,751% GainThe world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> OpGen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20247,800 shares $34,273.20 -95.9%0.6%0 $4.39 4/30/2024191,400 shares $77,134.20 +16.6%1.6%0.1 $0.40 4/15/2024164,100 shares $107,977.80 -92.6%1.4%0.1 $0.66 3/31/20242,230,000 shares $1.55 million +10,621.2%22.4%1.3 $0.70 3/15/202420,800 shares $10,004.80 -47.3%0.2%0 $0.48 2/29/202439,500 shares $18,865.20 -11.4%0.4%0.2 $0.48 Get the Latest News and Ratings for OPGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OpGen and its competitors with MarketBeat's FREE daily newsletter. 2/15/202444,600 shares $20,516.00 +88.2%0.5%0.2 $0.46 1/31/202423,700 shares $8,029.56 -23.8%0.2%0.1 $0.34 1/15/202431,100 shares $12,595.50 +19.2%0.3%0.1 $0.41 12/31/202326,100 shares $10,962.00 -62.1%0.3%0 $0.42 12/15/202368,900 shares $25,493.00 +302.9%0.7%0 $0.37 11/30/202317,100 shares $7,093.08 -84.9%0.2%0 $0.41 11/15/2023113,100 shares $54,288.00 -70.2%1.1%0 $0.48 10/31/2023379,900 shares $250,544.05 -60.1%4.3%0.1 $0.66 10/15/2023952,800 shares $783,201.60 +281.6%10.8%0.2 $0.82 9/30/2023249,700 shares $100,029.82 -7.3%2.8%0.1 $0.40 9/15/2023269,300 shares $61,400.40 -1.8%3.0%0.7 $0.23 8/31/2023274,300 shares $52,117.00 +63.3%3.1%0.7 $0.19 8/15/2023168,000 shares $37,816.80 +123.1%1.9%0.5 $0.23 7/31/202375,300 shares $45,255.30 -56.0%1.1%0.6 $0.60 7/15/2023171,200 shares $141,650.88 -47.7%2.8%0.8 $0.83 6/30/2023327,400 shares $266,798.26 -20.2%5.4%1.4 $0.81 6/15/2023410,100 shares $250,202.01 +52.5%6.8%1.5 $0.61 5/31/2023268,900 shares $202,105.24 +16.7%4.4%0.7 $0.75 5/15/2023230,500 shares $161,350.00 +11.8%3.8%0.6 $0.70 4/30/2023206,100 shares $163,705.23 +127.0%3.8%0.4 $0.79 4/15/202390,800 shares $103,512.00 -70.1%1.7%0.2 $1.14 3/31/2023303,400 shares $403,522.00 -44.4%5.6%0.7 $1.33 3/15/2023545,300 shares $714,343.00 +272.5%10.0%1.2 $1.31 2/28/2023146,400 shares $152,256.00 +27.6%5.5%0.3 $1.04 2/15/2023114,700 shares $123,876.00 -27.6%4.3%0.2 $1.08 1/31/2023158,500 shares $288,470.00 +17.0%5.9%0.4 $1.82 1/15/2023135,500 shares $352,300.00 -47.5%5.1%0.5 $2.60 12/30/2022258,100 shares $36,392.10 -95.3%9.7%0.9 $0.14 12/15/20225,440,000 shares $865,504.00 +1,238.6%N/A1.2 $0.16 11/30/2022406,400 shares $80,467.20 +2.0%N/A1.1 $0.20 11/15/2022398,600 shares $87,691.60 -0.2%N/A1.2 $0.22 10/31/2022399,200 shares $75,848.00 +117.7%N/A1.2 $0.19 10/15/2022183,400 shares $34,846.00 -33.7%N/A0.5 $0.19 9/30/2022276,500 shares $79,134.30 -4.3%N/A0.8 $0.29Biotech's Best Kept Secret: Potential 46,751% Gain (Ad)The world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> 9/15/2022288,800 shares $124,184.00 +3.8%N/A1 $0.43 8/31/2022278,200 shares $129,613.38 -48.7%N/A0.9 $0.47 8/15/2022541,900 shares $318,312.06 -35.6%N/A1.3 $0.59 7/31/2022841,000 shares $412,090.00 -5.9%N/A1.8 $0.49 7/15/2022893,600 shares $491,480.00 -7.0%N/A2.2 $0.55 6/30/2022961,100 shares $524,280.05 -2.8%N/A2.1 $0.55 6/15/2022988,800 shares $524,855.04 -20.3%N/A2.1 $0.53 5/31/20221,240,000 shares $855,600.00 +13.8%N/A2.6 $0.69 5/15/20221,090,000 shares $377,140.00 -7.6%N/A2.9 $0.35 4/30/20221,180,000 shares $617,140.00 +1.7%N/A4 $0.52 4/15/20221,160,000 shares $881,484.00 -0.9%N/A4 $0.76 3/31/20221,170,000 shares $877,617.00 +211.3%N/A4.1 $0.75 3/15/2022375,800 shares $308,531.80 -11.0%N/A0.8 $0.82 2/28/2022422,400 shares $346,368.00 +28.7%N/A0.7 $0.82 2/15/2022328,200 shares $299,351.22 +3.9%N/A0.5 $0.91 1/31/2022315,900 shares $277,992.00 +18.4%N/A0.4 $0.88 1/15/2022266,900 shares $261,535.31 +27.8%N/A0.3 $0.98 12/31/2021208,900 shares $208,900.00 -36.2%N/A0.2 $1.00 12/15/2021327,300 shares $399,306.00 -37.8%N/A0.1 $1.22 11/30/2021526,300 shares $847,343.00 -35.5%N/A0.2 $1.61 11/15/2021815,700 shares $1.40 million -14.1%N/A0.3 $1.72 10/29/2021949,000 shares $1.70 million -45.8%N/A0.4 $1.79 10/15/20211,750,000 shares $3.55 million +129.3%N/A0.6 $2.03 9/30/2021763,300 shares $2.20 million +29.6%2.0%0.3 $2.88 9/15/2021588,900 shares $1.85 million -24.3%1.5%0.5 $3.14 8/31/2021777,900 shares $2.49 million +50.6%2.0%0.6 $3.20 8/13/2021516,400 shares $1.34 million +119.6%1.4%0.5 $2.59 7/30/2021235,200 shares $595,056.00 -29.7%0.6%0.3 $2.53 7/15/2021334,500 shares $759,315.00 -11.0%0.9%0.4 $2.27 6/30/2021376,000 shares $853,520.00 +108.2%1.0%0.4 $2.27 6/15/2021180,600 shares $428,022.00 -13.6%0.5%0.2 $2.37 5/28/2021209,000 shares $457,710.00 -57.5%0.6%0.1 $2.19 5/14/2021492,000 shares $979,080.00 -23.3%N/A0.1 $1.99 4/30/2021641,700 shares $1.51 million -25.8%N/A0.1 $2.36 4/15/2021864,500 shares $2.19 million -14.4%N/A0.1 $2.53 3/31/20211,010,000 shares $2.54 million +15.6%N/A0.1 $2.51 3/15/2021873,400 shares $2.57 million +47.7%N/A0.1 $2.94 2/26/2021591,400 shares $1.40 million -9.7%N/A0.1 $2.37 2/12/2021654,600 shares $1.90 million -43.6%N/A0.2 $2.91 1/29/20211,160,000 shares $2.58 million -28.4%N/A0.4 $2.22 1/15/20211,620,000 shares $3.43 million -37.2%N/A1.3 $2.12 12/31/20202,580,000 shares $4.90 million +26.5%N/A2.3 $1.90 12/15/20202,040,000 shares $3.79 million +10.3%N/A2.6 $1.86 11/30/20201,850,000 shares $3.74 million +20.9%N/A2.5 $2.02 11/15/20201,530,000 shares $3.14 million -11.6%N/A1.9 $2.05 10/30/20201,730,000 shares $3.74 million -18.8%N/A0.6 $2.16 10/15/20202,130,000 shares $5.26 million -4.9%N/A0.3 $2.47 9/30/20202,240,000 shares $4.75 million +13.1%N/A0.3 $2.12 9/15/20201,980,000 shares $4.32 million -4.8%N/A0.3 $2.18 8/31/20202,080,000 shares $4.43 million +13.7%N/A0.3 $2.13Biotech's Best Kept Secret: Potential 46,751% Gain (Ad)The world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> 8/14/20201,830,000 shares $4.04 million +7.0%N/A0.3 $2.21 7/31/20201,710,000 shares $3.69 million +42.5%11.4%0.3 $2.16 7/15/20201,200,000 shares $2.44 million +3.5%8.0%0.9 $2.03 6/30/20201,160,000 shares $2.37 million +19.1%7.7%1 $2.04 6/15/2020974,300 shares $1.95 million +13.1%6.5%0.9 $2.00 5/29/2020861,500 shares $1.67 million +13.1%5.7%0.4 $1.94 5/15/2020761,500 shares $1.50 million +49.4%5.1%0.3 $1.97 4/30/2020509,600 shares $1.17 million +7.4%5.0%0.2 $2.29 4/15/2020474,600 shares $1.09 million -78.9%4.8%0.2 $2.30 3/31/20202,250,000 shares $4.97 million +228.3%18.9%0.8 $2.21 3/13/2020685,400 shares $1.50 million +14.1%12.3%0.3 $2.19 2/28/2020600,900 shares $1.88 million +24.0%10.8%0.4 $3.13 2/14/2020484,500 shares $1.10 million +22.9%8.7%0.5 $2.28 1/31/2020394,100 shares $587,209.00 +387.1%7.1%0.4 $1.49 1/15/202080,900 shares $144,002.00 -61.7%1.5%0.1 $1.78 12/31/2019211,200 shares $361,152.00 +308.5%3.8%0.3 $1.71 8/15/201987,900 shares $23,733.00 +15.8%1.1%0.2 $0.27 OPGN Short Interest - Frequently Asked Questions What is OpGen's current short interest? Short interest is the volume of OpGen shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 7,800 shares of OPGN short. 0.64% of OpGen's shares are currently sold short. Learn More on OpGen's current short interest. What is a good short interest percentage for OpGen? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.64% of OpGen's floating shares are currently sold short. Is OpGen's short interest increasing or decreasing? OpGen saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 7,800 shares, a decline of 95.9% from the previous total of 191,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is OpGen's float size? OpGen currently has issued a total of 1,260,000 shares. Some of OpGen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. OpGen currently has a public float of 1,220,000 shares. How does OpGen's short interest compare to its competitors? 0.64% of OpGen's shares are currently sold short. Here is how the short interest of companies compare to OpGen: Psychemedics Co. (0.20%), DermTech, Inc. (8.94%), BioNexus Gene Lab Corp. (1.33%), Fresh2 Group Limited (0.20%), Aclarion, Inc. (2.81%), Invitae Co. (26.15%), Centogene (0.23%), T2 Biosystems, Inc. (22.49%), Laboratory Co. of America Holdings (2.77%), Quest Diagnostics Incorporated (2.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short OpGen stock? Short selling OPGN is an investing strategy that aims to generate trading profit from OpGen as its price is falling. OPGN shares are trading down $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against OpGen? A short squeeze for OpGen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OPGN, which in turn drives the price of the stock up even further. How often is OpGen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OPGN, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PMD Short Interest DMTK Short Interest BGLC Short Interest FRES Short Interest ACON Short Interest NVTA Short Interest CNTG Short Interest TTOO Short Interest LH Short Interest DGX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OPGN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OpGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
